Dan Housman

CEO at Courage Therapeutics

Dan is a serial entrepreneur who founded and led multiple companies in the healthcare technology space. His start-up Recombinant Data Corp. ["RDC"] focused on analytics on genomics and patient data to support translational research. Following the acquisition of RDC by Deloitte he remained at the company as a Managing Director of the Healthcare and Life Sciences practice leading initiatives around life sciences uses of analytics and AI for drug discovery and development. He holds a BS in Chemistry and Biology from MIT and continues to mentor entrepreneurs through the MIT VMS entrepreneurship service. He is a parent of daughter with Anorexia Nervosa and son with ARFID.


View in org chart


  • CEO

    Current role

View in org chart